Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fritz Offner

Showing results (31-40 of 126) with videos related to

Pageof 13
Sort By:
Acta Oncologica (Stockholm, Sweden)|August 6, 2016
Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLLPeter Hillmen, Ann Janssens, K Govind Babu, et al.
Leukemia Research|March 20, 2009
Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemiaJerina Boelens, Sofie Lust, Femke Van Bockstaele, et al.
Annals of Hematology|January 30, 2015
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphomaMyron S Czuczman, Stephen Kahanic, Andres Forero, et al.
Blood Cancer Journal|December 6, 2019
Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG studyMarinus van Oers, Lukas Smolej, Mario Petrini, et al.
Frontiers in Oncology|November 13, 2023
Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsiesPhilippe Decruyenaere, Edoardo Giuili, Kimberly Verniers, et al.
Anticancer Research|October 23, 2009
Xanthohumol activates the proapoptotic arm of the unfolded protein response in chronic lymphocytic leukemiaSofie Lust, Barbara Vanhoecke, Mireille VAN Gele, et al.
Blood|October 21, 2004
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphomaRobert Marcus, Kevin Imrie, Andrew Belch, et al.
Leukemia Research|September 4, 2012
ER stress in diffuse large B cell lymphoma: GRP94 is a possible biomarker in germinal center versus activated B-cell typeJerina Boelens, Jean-Philippe Jais, Barbara Vanhoecke, et al.
Nuclear Medicine Communications|December 4, 2004
Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro studyKatia Vandenbulcke, Hubert Thierens, Fritz Offner, et al.
Blood|February 28, 2002
Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34(+) cellsTessa C C Kerre, Greet De Smet, Magda De Smedt, et al.
Pageof 13

Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
Acta Oncologica (Stockholm, Sweden)|August 6, 2016
Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLLPeter Hillmen, Ann Janssens, K Govind Babu, et al.
Leukemia Research|March 20, 2009
Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemiaJerina Boelens, Sofie Lust, Femke Van Bockstaele, et al.
Annals of Hematology|January 30, 2015
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphomaMyron S Czuczman, Stephen Kahanic, Andres Forero, et al.
Blood Cancer Journal|December 6, 2019
Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG studyMarinus van Oers, Lukas Smolej, Mario Petrini, et al.
Frontiers in Oncology|November 13, 2023
Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsiesPhilippe Decruyenaere, Edoardo Giuili, Kimberly Verniers, et al.
Anticancer Research|October 23, 2009
Xanthohumol activates the proapoptotic arm of the unfolded protein response in chronic lymphocytic leukemiaSofie Lust, Barbara Vanhoecke, Mireille VAN Gele, et al.
Blood|October 21, 2004
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphomaRobert Marcus, Kevin Imrie, Andrew Belch, et al.
Leukemia Research|September 4, 2012
ER stress in diffuse large B cell lymphoma: GRP94 is a possible biomarker in germinal center versus activated B-cell typeJerina Boelens, Jean-Philippe Jais, Barbara Vanhoecke, et al.
Nuclear Medicine Communications|December 4, 2004
Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro studyKatia Vandenbulcke, Hubert Thierens, Fritz Offner, et al.
Blood|February 28, 2002
Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34(+) cellsTessa C C Kerre, Greet De Smet, Magda De Smedt, et al.
Pageof 13